Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery

Clinical trial NCT00290355 · COMPLETED

Trial details

NCT number: NCT00290355
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer, Non-Small Cell

Start date: 2002-05-28
Primary completion: 2011-07-19
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.